Saving Lives Through Science: Dr. Gabi Hanna on Innovation, Heritage & Global Impact | Episode #22

In this episode of the Kano Talk Show, we sit down with Dr. Gabi
Hanna, CEO and co-founder of Lamassu BioTech, to talk about his
inspiring journey from Qamishli, Syria, to leading cutting-edge
drug development in the United States.With a mission to “Save
More Lives Everywhere”, Dr. Hanna shares how Lamassu BioTech is
bringing transformational treatments from concept to bedside
faster — with a patient-first approach that tackles unmet medical
needs in oncology and acute pancreatitis.We discuss: His personal
journey from Aleppo University Medical School to the US The
importance of translational research for real-world impact How
Lamassu’s breakthrough therapies (SAYDI-53 & RABI-767) could
change the future of cancer and pancreatitis treatment The values
of service, excellence, and heritage that guide his workFrom
small-town beginnings to global impact, Dr. Hanna’s story is
about science, service, and saving lives. Jetzt anschauen,
abonnieren & teilen!SPENDEN FÜR DIE KANO TALK
SHOW:https://www.paypal.com/donate/?hosted_button_id=DWHWPAL2G875JFIND
OUT MORE ABOUT OUR GUEST:www.LamassuBioTech.comFIND OUT MORE
ABOUT US:https://www.kano-s.de/FOLLOW US ON SOCIAL:Instagram:
https://www.instagram.com/kano_suryoyo/Facebook:
https://www.facebook.com/KanoSuryoyo/?locale=de_DETikTok:
https://www.tiktok.com/@kano_suryoyoPRODUCED
BY:https://www.instagram.com/malkimedia.de/https://www.linkedin.com/in/mario-malki/https://www.malkimedia.com/Anfragen
für Sponsoring oder Feedback an:info@kano-s.de#GabiHanna
#LamassuBioTech #KanoTalkShow #DrugDevelopment #Oncology
#CancerResearch #Pancreatitis #MedicalInnovation
#FromSyriaToSuccess #TranslationalResearch #HealthcareLeadership
#healthcare #cancer